Current management of pancreatic carcinoma.
OBJECTIVE
The author seeks to provide an update on the current management of pancreatic carcinoma, including diagnosis and staging, surgical resection and adjuvant therapy for curative intent, and palliation.


BACKGROUND
During the 1960s and 1970s, the operative mortality and long-term survival after pancreaticoduodenectomy for pancreatic carcinoma was so poor that some authors advocated abandoning the procedure. Several recent series have reported a marked improvement in perioperative results with 5-year survival in excess of 20%. Significant advances also have been made in areas of preoperative evaluation and palliation for advanced disease.


CONCLUSIONS
Although carcinoma of the pancreas remains a disease with a poor prognosis, advances in the last decade have led to improvements in the overall management of this disease. Resection for curative intent currently should be accomplished with minimal perioperative mortality. Surgical palliation also may provide the optimal management of selected patients.
Lillemoe
K D
KD
Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland.
D000230:Adenocarcinoma / Q000175:diagnosis / Q000628:therapy; D003131:Combined Modality Therapy; D003952:Diagnostic Imaging; D006801:Humans; D009367:Neoplasm Staging; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000628:therapy; D016577:Pancreaticoduodenectomy; D011379:Prognosis; D016896:Treatment Outcome